1-12 of 12
Gaixiang Xu
Close
Sort by
Journal Articles

Analysis of Clinical Features, Prognostic Characteristics and Gene Mutations of the EB Subtype of Primary Myelodysplastic Syndrome Patients with Myelofibrosis

Gaixiang Xu, Wei Wang, Shuanghong Zhu, Kongfei Li, Xinping Zhou, Liya Ma, Li Ye, Chen Mei, Lu Wang, Lingxu Jiang, Haitao Meng, Wen-Juan Yu, Jie Jin, Hongyan Tong, Jian Huang
Journal: Blood
Blood (2023) 142 (Supplement 1): 6481.
https://doi.org/10.1182/blood-2023-184789
Published: 2023
Journal Articles

High Expressions of Checkpoint Receptors in T Cells Subsets of Myelodysplastic Syndromes Patients with TP53 Mutations

Lingxu Jiang, Xin Huang, Xinping Zhou, Li Ye, Lu Wang, Chen Mei, Liya Ma, Gaixiang Xu, Chao Hu, Ziyang Zhou, Xiaozhen Liu, Yueyuan Han, Zheng Ge, Hongyan Tong
Journal: Blood
Blood (2023) 142 (Supplement 1): 4614.
https://doi.org/10.1182/blood-2023-182601
Published: 2023
Journal Articles

Risk Factors for Severe Infection and Unfavorable Outcomes in Hematologic Malignancy Patients with COVID-19 Inflection during the Omicron Era: A Chinese Single-Center Retrospective Study

Li Ye, Ye Yang, Xuewu Zhang, Lu Wang, Li Zhu, Xia Li, Yile Zhou, Xiaolong Zheng, Xinping Zhou, Yanling Ren, Liya Ma, Gaixiang Xu, Chunmei Yang, Huafeng Wang, De Zhou, Min Yang, Xingnong Ye, Juying Wei, Wen-Juan Yu, Jiejing Qian, Yinjun Lou, Wanzhuo Xie, Jian Huang, Haitao Meng, Jie Jin, Hongyan Tong
Journal: Blood
Blood (2023) 142 (Supplement 1): 5384.
https://doi.org/10.1182/blood-2023-184470
Published: 2023
Journal Articles

How Induction Cycles before Remission Influence Long-Term Survival in Acute Myeloid Leukemia

Feng Zhu, Nianci Chen, Yile Zhou, Yi Zhang, Jian Huang, Wanzhuo Xie, Haitao Meng, Wen-Juan Yu, Liping Mao, Wenyuan MAI, Chunmei Yang, Juying Wei, Yinjun Lou, Min Yang, Jiejing Qian, Gaixiang Xu, De Zhou, Liya Ma, Xingnong Ye, Yanling Ren, Hongyan Tong, Huafeng Wang, Jie Jin
Journal: Blood
Blood (2023) 142 (Supplement 1): 6001.
https://doi.org/10.1182/blood-2023-186048
Published: 2023
Journal Articles

Combination of Olverembatinib and VP Regimen As First-Line Therapy for Adult Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

Gaixiang Xu, Yinjun Lou, Huafeng Wang, Wen-Juan Yu, Liping Mao, Jian Huang, Chenying Li, Shanshan Suo, Hongyan Tong, Jie Jin
Journal: Blood
Blood (2023) 142 (Supplement 1): 4205.
https://doi.org/10.1182/blood-2023-187130
Published: 2023
Journal Articles

Gilteritinib-Based Combination Therapy in Adult Relapsed/Refractory FLT3 Mutated Acute Myeloid Leukemia

Nianci Chen, Jiajia Pan, Yile Zhou, Liping Mao, Yinjun Lou, Jiejing Qian, Gaixiang Xu, Juying Wei, De Zhou, Lihong Shou, Huang Li, Minchao Yan, Hui Zeng, Cuihua Fan, Gongqiang Wu, Weiying Feng, Hongyan Tong, Jie Jin, Huafeng Wang
Journal: Blood
Blood (2023) 142 (Supplement 1): 5926.
https://doi.org/10.1182/blood-2023-182806
Published: 2023
Journal Articles

Safety and Efficacy of Selinexor Sequential Azacytidine in Newly Diagnosed Patients with Myelodysplastic Syndromes EB1 or EB2: A Single-Center, Single-Arm, Phase Ib/II Trial

Liya Ma, Wenli Yang, Xinping Zhou, Li Ye, Gaixiang Xu, Chao Hu, Yingwan Luo, Chunmei Yang, Zheng Ge, Hongyan Tong
Journal: Blood
Blood (2023) 142 (Supplement 1): 1856.
https://doi.org/10.1182/blood-2023-183101
Published: 2023
Journal Articles

Olverembatinib Plus Low-Intensive Regimen in Frontline Therapy for Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia： a Case Series from a Single Center

Yinjun Lou, Gaixiang Xu, Huafeng Wang, Liping Mao, Hongyan Tong, Jie Jin
Journal: Blood
Blood (2022) 140 (Supplement 1): 11683–11684.
https://doi.org/10.1182/blood-2022-165879
Published: 2022
Journal Articles

The M6A Methyltransferase METTL14 Promotes Myelodysplastic Syndromes Development Via PI3K/Akt Signaling Pathway

Lingxu Jiang, Xinping Zhou, Chao Hu, Chen Mei, Gaixiang Xu, Liya Ma, Yanling Ren, Li Ye, Lu Wang, Yingwan Luo, Jie Jin, Jie Sun, Hongyan Tong
Journal: Blood
Blood (2022) 140 (Supplement 1): 6894–6895.
https://doi.org/10.1182/blood-2022-165203
Published: 2022
Journal Articles

EZH2 Inhibition Mediates Proptosis Via DHX9 and S100A9 in Myelodysplastic Syndromes

Qi Zhang, Wei Lang, Lu Wang, Wenli Yang, Yingwan Luo, Shuanghong Zhu, Lingxu Jiang, Yuxia Wang, Chen Mei, Xinping Zhou, Yanling Ren, Liya Ma, Li Ye, Xingnong Ye, Gaixiang Xu, Jie Sun, Jie Jin, Hongyan Tong
Journal: Blood
Blood (2022) 140 (Supplement 1): 9767–9768.
https://doi.org/10.1182/blood-2022-165886
Published: 2022
Journal Articles

Analysis of Clinical Features, Prognostic Characteristics and Gene Mutations of Primary Myelodysplastic Syndrome Patients with Myelofibrosis

Gaixiang Xu, Shuanghong Zhu, Xinping Zhou, Kongfei Li, Lingxu Jiang, Hongyan Tong, Jie Jin
Journal: Blood
Blood (2022) 140 (Supplement 1): 9796–9797.
https://doi.org/10.1182/blood-2022-165344
Published: 2022
Journal Articles

Venetoclax Combined with Daunorubicin and Cytarabine (DAV) As Induction Therapy in De Novo Young Adult Acute Myeloid Leukemia

Huafeng Wang, Liping Mao, Wanzhuo Xie, Hongyan Tong, Min Yang, Gaixiang Xu, Xiujin Ye, Ying Lu, Juying Wei, Wenyuan Mai, De Zhou, Jie Jin, Hong-Hu Zhu
Journal: Blood
Blood (2021) 138 (Supplement 1): 2334.
https://doi.org/10.1182/blood-2021-153257
Published: 2021